Argenx to report full year 2024 financial results and fourth quarter business update on february 27, 2025

February 20, 2025 amsterdam, the netherlands – argenx (euronext & nasdaq: argx), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on thursday, february 27, 2025 at 2:30 pm cet (8:30 am et) to discuss its full year 2024 financial results and provide a fourth quarter business update.
ARGX Ratings Summary
ARGX Quant Ranking